Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma

DNA and Cell Biology

Volumn 27, Issue 10, 2008, Pages 553-557

  Wu, Jin ^a   Zhang, Lin ^a   Luo, Hao ^a   Zhu, Zhendong ^a   Zhang, Conghai ^a   Hou, Yiping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 52749094641     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0732     Document Type: Article

References (32)

1. Adachi, Y., Yamamoto, H., Itoh, F., Hinoda, Y., Okada, Y., and Imai, K. (1999). Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45, 252-258.
2. Aglund, K., Rauvala, M., Puistola, U., Angstrom, T., Turpeenniemi- Hujanen, T., Zackrisson, B., and Stendahl, U. (2004). Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol 94, 699-704.
3. Allan, J.A., Docherty, A.J., Barker, P.J., Huskisson, N.S., Reynolds, J.J., and Murphy, G. (1995). Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 309 (Pt 1), 299-306.
4. Bode, W., Fernandez-Catalan, C., Tschesche, H., Grams, F., Nagase, H., and Maskos, K. (1999). Structural properties of matrix metalloproteinases. Cell Mol Life Sci 55, 639-652.
5. Curran, S., and Murray, G.I. (1999). Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 189, 300-308.
6. Devesa, S.S., Blot, W.J., and Fraumeni, J.F., Jr. (1998). Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83, 2049-2053.
7. Guo, W., Blot, W.J., Li, J.Y., Taylor, P.R., Liu, B.Q., Wang, W., Wu, Y.P., Zheng, W., Dawsey, S.M., Li, B., and Fraumeni, J.F., Jr. (1994). A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial. Int J Epidemiol 23, 444-450.
8. Hu, Z., Huo, X., Lu, D., Qian, J., Zhou, J., Chen, Y., Xu, L., Ma, H., Zhu, J., Wei, Q., and Shen, H. (2005). Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 11, 5433-5439.
9. Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., and Uehira, M. (1999). Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17, 177-181.
10. Jordan, R.C., Macabeo-Ong, M., Shiboski, C.H., Dekker, N., Ginzinger, D.G., Wong, D.T., and Schmidt, B.L. (2004). Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res 10, 6460-6465.
11. Ke, X., Collins, A., and Ye, S. (2001). PIRA PCR designer for restriction analysis of single nucleotide polymorphisms. Bioinformatics 17, 838-839.
12. Koyama, H., Iwata, H., Kuwabara, Y., Iwase, H., Kobayashi, S., and Fujii, Y. (2000). Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography. Eur J Cancer 36, 2164-2170.
13. Li, J., Brick, P., O'Hare, M.C., Skarzynski, T., Lloyd, L.F., Curry, V.A., Clark, I.M., Bigg, H.F., Hazleman, B.L., Cawston, T.E., and Blow, D.M. (1995). Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 3, 541-549.
14. Matsha, T., Erasmus, R., Kafuko, A.B., Mugwanya, D., Stepien, A., and Parker, M.I. (2002). Human papillomavirus associated with oesophageal cancer. J Clin Pathol 55, 587-590.
15. Matsumura, S., Oue, N., Nakayama, H., Kitadai, Y., Yoshida, K., Yamaguchi, Y., Imai, K., Nakachi, K., Matsusaki, K., Chayama, K., and Yasui, W. (2005). A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131, 19-25.
16. Mogg, R., Batley, J., Hanley, S., Edwards, D., O'Sullivan, H., and Edwards, J. (2002). Characterization of the flanking regions of Zea mays microsatellites reveals a large number of useful sequence polymorphisms. Theor Appl Genet 105, 532-543.
17. Murphy, G., and Knauper, V. (1997). Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol 15, 511-518.
18. O'Farrell, T.J., and Pourmotabbed, T. (2000). Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-like domain and active site of gelatinase B. J Biol Chem 275, 27964-27972.
19. Parsons, S.L., Watson, S.A., Brown, P.D., Collins, H.M., and Steele, R.J. (1997). Matrix metalloproteinases. Br J Surg 84, 160-166.
20. Pisani, P., Parkin, D.M., Bray, F., and Ferlay, J. (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83, 18-29.
21. Song, C., Xing, D., Tan, W., Wei, Q., and Lin, D. (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61, 3272-3275.
22. Stamenkovic, I. (2000). Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10, 415-433.
23. Stephens, M., and Donnelly, P. (2003). A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73, 1162-1169.
24. Sternlicht, M.D., and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17, 463-516.
25. van Gijssel, H.E., Divi, R.L., Olivero, O.A., Roth, M.J., Wang, G.Q., Dawsey, S.M., Albert, P.S., Qiao, Y.L., Taylor, P.R., Dong, Z.W., Schrager, J.A., Kleiner, D.E., and Poirier, M.C. (2002). Semiquantitation of polycyclic aromatic hydrocarbon-DNA adducts in human esophagus by immunohistochemistry and the automated cellular imaging system. Cancer Epidemiol Biomarkers Prev 11, 1622-1629.
26. Wen, H., Zhang, L., Li, J., and Zhang, Y. (2005). Expression of matrix metalloproteinase-2, -9 in human esophageal cancer tissue[J]. J Zhengzhou Univ (Med Sci) 40, 497-499.
27. Wilson, C.L., and Matrisian, L.M. (1996). Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28, 123-136.
28. Ye, S. (2000). Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19, 623-629.
29. Yokokawa, Y., Ohta, S., Hou, J., Zhang, X.L., Li, S.S., Ping, Y.M., and Nakajima, T. (1999). Ecological study on the risks of esophageal cancer in Ci-Xian, China: the importance of nutritional status and the use of well water. Int J Cancer 83, 620-624.
30. Zhang, J., Cui, Y., Kuang, G., Li, Y., Wang, N., Wang, R., Guo, W., Wen, D., Wei, L., Yu, F., and Wang, S. (2004). Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis 25, 2479-2485.
31. Zhang, J., Li, Y., Wang, R., Wen, D., Sarbia, M., Kuang, G., Wu, M., Wei, L., He, M., Zhang, L., and Wang, S. (2003a). Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 105, 281-284.
32. Zhang, J., Schulz, W.A., Li, Y., Wang, R., Zotz, R., Wen, D., Siegel, D., Ross, D., Gabbert, H.E., and Sarbia, M. (2003b). Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 24, 905-909.